Author

Alicia Sanoyca

University of California, Los AngelesORCID 0009-0004-2238-9683Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Assay:CRISPR screen· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Beate IllekiD· 1 shared Brigitte N. GompertsiD· 1 shared Colin J. JuettiD· 1 shared Donald B. KohniD· 1 shared Emily C. DugganiD· 1 shared Kevin J. CooteiD· 1 shared Lindsay E. LathropiD· 1 shared Paul George AyoubiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Beate IllekORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Lipid Nanoparticles for the Delivery of CRISPR/Cas9 Machinery to Enable Site-Specific Integration of CFTR and Mutation-Agnostic Disease Rescue

Ruth A. Foley, Paul George Ayoub, Vrishti Sinha, Colin J. Juett, Alicia Sanoyca, Emily C. Duggan, Lindsay E. Lathrop, Priyanka Bhatt, Kevin J. Coote, Beate Illek, Brigitte N. Gomperts, Donald B. Kohn, Steven John Jonas

This paper develops lipid nanoparticles to deliver CRISPR/Cas9 for site-specific CFTR gene integration in CF airway cells, achieving 3-3.5% gene editing and 80% Cl- current restoration.

Advanced Functional Materials · Jan 4, 2026Peer-reviewedBioengineering